pentosidine has been researched along with Body Weight in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arvindekar, AU; Haldavnekar, VS; Joglekar, MM; Panaskar, SN; Taklikar, SS | 1 |
Chang, CY; Chang, KC; Chang, RW; Chen, YS; Ko, WJ; Ko, YH; Tsai, PR; Wang, CH; Wang, SS; Young, TH | 1 |
Kruger, R; Mokwatsi, GG; Schutte, AE | 1 |
Fujimoto, S; Miyazaki, A; Yoshikawa, T | 1 |
Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H | 1 |
Cutler, RG; Handy, A; Ingram, DK; Lane, MA; Mattison, JA; Monnier, VM; Obrenovich, ME; Roth, GS; Sell, DR | 1 |
Cosso, L; Marinari, UM; Noberasco, G; Odetti, P; Pronzato, MA; Traverso, N | 1 |
Alhumadi, NH; Iqbal, M; Klandorf, H; Probert, LL | 1 |
Iqbal, M; Klandorf, H; Rathore, DS; Shi, X; Van Dyke, K | 1 |
Monnier, VM; Richard, S; Sell, DR; Tamas, C | 1 |
1 trial(s) available for pentosidine and Body Weight
Article | Year |
---|---|
Decrease in serum levels of advanced glycation end-products by short-term lifestyle modification in non-diabetic middle-aged females.
Topics: Adiposity; Adult; Aged; Arginine; Body Weight; Case-Control Studies; Diabetes Mellitus; Exercise; Female; Glycation End Products, Advanced; Humans; Life Style; Lysine; Middle Aged; Regression Analysis; Time Factors; Walking | 2009 |
9 other study(ies) available for pentosidine and Body Weight
Article | Year |
---|---|
Aegle marmelos Correa leaf extract prevents secondary complications in streptozotocin-induced diabetic rats and demonstration of limonene as a potent antiglycating agent.
Topics: Aegle; Animals; Antioxidants; Arginine; Body Weight; Cataract; Collagen; Cyclohexenes; Diabetes Mellitus, Experimental; Eating; Glycation End Products, Advanced; Hypoglycemic Agents; Kidney; Limonene; Lysine; Male; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Terpenes | 2013 |
Prevention of arterial stiffening by using low-dose atorvastatin in diabetes is associated with decreased malondialdehyde.
Topics: Animals; Arginine; Atorvastatin; Blood Glucose; Blood Pressure; Body Weight; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fatty Acids; Glycation End Products, Advanced; Hemodynamics; Heptanoic Acids; Lysine; Male; Malondialdehyde; Organ Size; Pyrroles; Rats, Wistar; Streptozocin; Vascular Stiffness | 2014 |
Ethnic differences regarding arterial stiffness of 6-8-year-old black and white boys.
Topics: Arginine; Arteries; Black People; Body Composition; Body Mass Index; Body Weight; Carotid Arteries; Carotid Intima-Media Thickness; Child; Compliance; Glycation End Products, Advanced; Humans; Hypertension; Lysine; Male; Pulse Wave Analysis; Vascular Stiffness; Waist Circumference; White People | 2017 |
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles | 2003 |
The effect of caloric restriction on glycation and glycoxidation in skin collagen of nonhuman primates.
Topics: Aging; Analysis of Variance; Animals; Arginine; Biomarkers; Body Weight; Chromatography, High Pressure Liquid; Collagen; Food Deprivation; Glucose; Glucose Tolerance Test; Glycation End Products, Advanced; Longevity; Lysine; Macaca mulatta; Oxidation-Reduction; Regression Analysis; Saimiri; Skin | 2003 |
Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats.
Topics: Abdomen; Aging; Analysis of Variance; Animals; Arginine; Blood Glucose; Body Weight; Collagen; Diabetes Mellitus, Type 1; Disease Models, Animal; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosylation; Hydroxyproline; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lysine; Male; Oxidation-Reduction; Random Allocation; Rats; Rats, Inbred BB; Spectrometry, Fluorescence | 1996 |
Protein glycosylation and advanced glycosylated endproducts (AGEs) accumulation: an avian solution?
Topics: Aging; Animals; Arginine; Blood Glucose; Body Weight; Chickens; Cross-Linking Reagents; Diet; Enzyme Inhibitors; Female; Glycation End Products, Advanced; Glycosylation; Guanidines; Hyperglycemia; Leukocytes; Lysine; Oxidative Stress; Random Allocation; Respiratory Burst; Skin; Uric Acid | 1999 |
Accelerated tissue aging and increased oxidative stress in broiler chickens fed allopurinol.
Topics: Aging; Allopurinol; Animals; Antimetabolites; Arginine; Blood Glucose; Body Weight; Chickens; Cross-Linking Reagents; Diet; Glycation End Products, Advanced; Glycosylation; Hemin; Luminescent Measurements; Lysine; Muscle, Skeletal; Oxidative Stress; Skin; Uric Acid | 2001 |
Tissue-specific effects of aldose reductase inhibition on fluorescence and cross-linking of extracellular matrix in chronic galactosemia. Relationship to pentosidine cross-links.
Topics: Aldehyde Reductase; Animals; Arginine; Body Weight; Collagen; Extracellular Matrix; Galactosemias; Glycated Hemoglobin; Imidazoles; Imidazolidines; Lysine; Male; Rats; Rats, Inbred Strains; Reference Values; Spectrometry, Fluorescence; Tendons | 1991 |